Dawson James Starts Collplant Holdings Inc. (CLGN) at Buy

November 4, 2019 7:07 AM EST
Get Alerts CLGN Hot Sheet
Price: $5.37 -0.92%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 14 | Down: 18 | New: 17
Join SI Premium – FREE

Dawson James analyst Jason Kolbert initiates coverage on Collplant Holdings Inc. (NASDAQ: CLGN) with a Buy rating and a price target of $9.00.

The analyst commented, "CollPlant is a bioengineering company developing, manufacturing, and commercializing regenerative medicine products. CollPlant’s focus is on its proprietary technology platform, which mass produces recombinant human collagen (rhCollagen) sourced from tobacco plants. CollPlant uses this rhCollagen to 3d bioprint tissues, organs, and other medical aesthetic products. CollPlant currently has a Strategic agreement with United Therapeutics (NASDAQ: UTHR) for 3D bioprinting of lung transplants and other life-saving organs. Multiple other partners are expected to emerge over the next few years."

For an analyst ratings summary and ratings history on Collplant Holdings Inc. click here. For more ratings news on Collplant Holdings Inc. click here.

Shares of Collplant Holdings Inc. closed at $4.67 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage